Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.45 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.37 |
| ▸ | DDAH1 | O94760 | 3/20 | 0.37 |
| ▸ | NOS1 | P29475 | 3/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.35 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.34 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.34 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | LTA4H | P09960 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | ENPEP | Q07075 | 2/20 | 0.33 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.33 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5322830 | 0.90 | ALOX15 (0.52) | KMT2AALOX15BLMPMP22SLC7A5 | |
| SCHEMBL5320858 | 0.87 | KMT2A (0.44) | KMT2AALOX15BLMPMP22SLC7A5 | |
| SCHEMBL29634861 | 0.84 | CA2 (0.52) | SLC7A5CA2MAPK1SLC1A2SLC1A1 | |
| SCHEMBL4774070 | 0.84 | CA2 (0.52) | SLC7A5CA2MAPK1SLC1A2SLC1A1 | |
| SCHEMBL27637001 | 0.84 | CA2 (0.52) | SLC7A5CA2MAPK1SLC1A2SLC1A1 | |
| SCHEMBL21054367 | 0.82 | GSR (0.45) | SLC7A5CA2MAPK1SLC1A2SLC1A1 | |
| SCHEMBL21054364 | 0.82 | GSR (0.45) | SLC7A5CA2MAPK1SLC1A2SLC1A1 | |
| SCHEMBL5321316 | 0.81 | GSR (0.53) | SLC7A5FOLH1SLC1A2SLC1A1GRIK1 | |
| SCHEMBL7055852 | 0.79 | CHRM1 (0.46) | SLC7A5CA2MAPK1SLC1A2SLC1A1 | |
| SCHEMBL5319461 | 0.79 | GSR (0.52) | KMT2AALOX15FOLH1ALDH1A1GRIK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070258899-A1 | Diagnostic and therapeutic agents | KARYON-CTT LTD (FI) | 2007-11-08 | — | — | US | disclosed |
| WO-2007113385-A1 | DIAGNOSTIC AND THERAPEUTIC AGENTS | KARYON-CTT LTD (FI) | 2007-10-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070258899-A1 | Diagnostic and therapeutic agents | YBX1, MLX, TPX2 | KMT2A 3586/4885ALOX15 4182/4885BLM 2573/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.